Previously, LINC00461 was found to serve as oncogene and promote progression of different malignant tumors, such as hepatocellular carcinoma [9], multiple myeloma [10], breast cancer [11], and glioma [8,12] as well. Here, MIR9-2HG is linked to central nervous system cancer.